Clinical Trials Directory

Trials / Terminated

TerminatedNCT04338815

Exoskeleton Variability Optimization

Exoskeleton Variability Optimization for Reducing Gait Variability for Patients With Peripheral Artery Disease

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
All
Age
19 Years – 85 Years
Healthy volunteers
Accepted

Summary

Exoskeletons, wearable devices that assist with walking, can improve mobility in clinical populations. With exoskeletons, it is crucial to optimize the assistance profile. Recent studies describe algorithms (i.e., human-in-the-loop) to optimize the assistance profile with real-time metabolic measurements. The needed duration of current human-in-the-loop (HITL) algorithms range from 20 minutes to 1 hour which is longer than the average duration that most patients with peripheral artery disease (PAD) can walk. Because of this limited walking duration, it is often not possible for patients with PAD to reach steady-state metabolic cost, which makes these measurements are not useful for optimizing exoskeletons. In this study, investigators intend to develop and evaluate HITL optimization methods for exoskeletons and use the information to design and evaluate a portable hip exoskeleton. Shorter and more clinically feasible HITL optimization strategies based on experiments in healthy adults might allow utilizing these optimization strategies to become available for patient populations such as patients with PAD.

Detailed description

Exoskeletons, wearable devices that assist with walking, can improve mobility in clinical populations. With exoskeletons, it is crucial to optimize the assistance profile. Recent studies describe algorithms (i.e., human-in-the-loop) to optimize the assistance profile with real-time metabolic measurements. The needed duration of current human-in-the-loop (HITL) algorithms range from 20 minutes to 1 hour which is longer than the average duration that most patients with peripheral artery disease (PAD) can walk. Because of this limited walking duration, it is often not possible for patients with PAD to reach steady-state metabolic cost, which makes these measurements are not useful for optimizing exoskeletons. Shorter and more clinically feasible HITL optimization strategies based on experiments in healthy adults might allow utilizing these optimization strategies to become available for patient populations such as patients with PAD. This study will test different methods for optimizing exoskeletons. It will consist of an habituation session to the hip exoskeleton, an optimization session to find the optimal actuation settings using an algorithm that converges toward the optimum based on real-time measurements (human-in-the-loop algorithm) and a post-test at the end of optimization session to compare different conditions. The outcomes will be evaluated by surface electromyography, exoskeleton sensors, ground reaction force, walking speed, indirect calorimetry, and motion capture (Vicon).

Conditions

Interventions

TypeNameDescription
OTHERExoskeleton OptimizationParticipants will walk 10-minute trials while an optimization algorithm changes the assistance profile of the exoskeleton.
OTHEREndurance EvaluationParticipants will walk 2 trials at a speed of 1 meter per second until the participant indicates claudication or a maximum duration of 6 minutes, which ever comes first.

Timeline

Start date
2022-01-31
Primary completion
2025-03-28
Completion
2025-03-28
First posted
2020-04-08
Last updated
2025-06-19
Results posted
2025-06-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04338815. Inclusion in this directory is not an endorsement.